KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Receivables (2018 - 2025)

Historic Change in Receivables for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $1.0 billion.

  • Moderna's Change in Receivables fell 2769.45% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$503.0 million, marking a year-over-year decrease of 6655.63%. This contributed to the annual value of -$534.0 million for FY2024, which is 831.64% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Change in Receivables is $1.0 billion, which was down 2769.45% from -$30.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Change in Receivables peaked at $1.8 billion during Q1 2021, and registered a low of -$1.3 billion during Q4 2022.
  • For the 5-year period, Moderna's Change in Receivables averaged around -$17.4 million, with its median value being -$30.0 million (2025).
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 9085000.0% in 2021, then crashed by 2710000.0% in 2023.
  • Moderna's Change in Receivables (Quarter) stood at $33.0 million in 2021, then plummeted by 4069.7% to -$1.3 billion in 2022, then grew by 25.65% to -$974.0 million in 2023, then decreased by 23.82% to -$1.2 billion in 2024, then surged by 184.0% to $1.0 billion in 2025.
  • Its Change in Receivables was $1.0 billion in Q3 2025, compared to -$30.0 million in Q2 2025 and -$280.0 million in Q1 2025.